[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

How to Play QNT Stock After the Quantinuum IPO

Quantum computing has long sounded like a technology of the future, and few companies have attracted as much attention as Quantinuum Inc. (QNT) has recently. Created in 2021 through the merger of Honeywell’s (HON) quantum computing division and U.K.-based Cambridge Quantum, the company is building advanced quantum machines designed to solve problems that would take traditional computers an impractical amount of time to handle. Its technology could eventually be used across industries ranging from drug discovery and cybersecurity to finance, chemistry, and artificial intelligence (AI).

That vision helped fuel massive investor interest when Quantinuum went public this week....

Fundamentals

See More
  • Market Capitalization, $K 188,671,120
  • Shares Outstanding, K 539,708
  • Annual Sales, $ 36,751 M
  • Annual Income, $ 7,711 M
  • EBIT $ 10,568 M
  • EBITDA $ 16,935 M
  • 60-Month Beta 0.42
  • Price/Sales 5.08
  • Price/Cash Flow 10.22
  • Price/Book 20.30

Options Overview Details

View History
  • Implied Volatility 28.40% (+1.69%)
  • Historical Volatility 26.34%
  • IV Percentile 63%
  • IV Rank 56.96%
  • IV High 35.00% on 04/07/26
  • IV Low 19.66% on 08/15/25
  • Expected Move (DTE 6) 10.82 (3.10%)
  • Put/Call Vol Ratio 1.52
  • Today's Volume 10,560
  • Volume Avg (30-Day) 8,944
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 125,652
  • Open Int (30-Day) 111,150
  • Expected Range 338.76 to 360.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 36 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $5.55
  • Number of Estimates 11
  • High Estimate $5.77
  • Low Estimate $5.30
  • Prior Year $6.02
  • Growth Rate Est. (year over year) -7.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
320.96 +8.92%
on 05/19/26
356.50 -1.94%
on 06/05/26
+19.99 (+6.07%)
since 05/05/26
3-Month
320.52 +9.07%
on 05/05/26
380.14 -8.04%
on 03/11/26
-18.02 (-4.90%)
since 03/05/26
52-Week
267.83 +30.52%
on 06/23/25
391.29 -10.66%
on 03/02/26
+62.48 (+21.76%)
since 06/05/25

Most Recent Stories

More News
How to Play QNT Stock After the Quantinuum IPO

Quantinuum’s IPO grabbed headlines, but its first trading day showed both excitement and caution. How can investors approach QNT stock after its Wall Street debut?

MITSY : 616.0600 (-2.73%)
EADSY : 51.3700 (+0.33%)
QNT : 56.26 (-6.82%)
HON : 213.97 (-1.69%)
JPM : 312.37 (+0.48%)
MIELY : 72.6500 (-3.21%)
BMWKY : 26.7501 (-1.29%)
AMGN : 349.58 (+1.15%)
Amgen Touts MariTide, AI Gains and 2026 Growth Plans at Jefferies Conference

Amgen (NASDAQ:AMGN) executives used a Jefferies investor conference appearance to emphasize the company’s first-quarter growth, its late-stage pipeline and its preparations for potential launches, including...

AMGN : 349.58 (+1.15%)
AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif. , June 4, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 47 th  Annual Global Healthcare Conference at 9:20 a.m. ET on Tuesday, June 9, 2026. Peter...

AMGN : 349.58 (+1.15%)
Honeywell Stock Is Likely to Reward Shareholders Following Quantinuum IPO, Split

HON will own a large stake in Quantinuum following the IPO.

EADSY : 51.3700 (+0.33%)
SNDK : 1,559.32 (-11.39%)
HON : 213.97 (-1.69%)
JPM : 312.37 (+0.48%)
ILMN : 162.32 (-3.42%)
WDC : 511.72 (-11.08%)
GRAL : 59.98 (-9.87%)
GEV : 933.61 (-3.09%)
BMWKY : 26.7501 (-1.29%)
AMGN : 349.58 (+1.15%)
GE : 328.00 (+0.11%)
AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026

New Phase 3 MITIGATE Open-Label Extension Data Support the Long-Term Safety Profile and Sustained Results of UPLIZNA ® in IgG4-RD

AMGN : 349.58 (+1.15%)
Dear Future Quantinuum Stock Investors, Mark Your Calendars for June 3

Investors may want to keep an eye on June 3 as Quantinuum is set to price its IPO and make a big move toward its Wall Street debut.

EADSY : 51.3700 (+0.33%)
HON : 213.97 (-1.69%)
JPM : 312.37 (+0.48%)
MS : 211.93 (-2.90%)
MIELY : 72.6500 (-3.21%)
BMWKY : 26.7501 (-1.29%)
AMGN : 349.58 (+1.15%)
How Is Gilead Sciences's Stock Performance Compared to Other Healthcare Stocks

Gilead Sciences has outperformed the healthcare sector, and analysts remain highly optimistic about the stock’s outlook

XLV : 153.01 (+0.61%)
GILD : 129.16 (-0.02%)
AMGN : 349.58 (+1.15%)
Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector?

Despite Vertex Pharmaceuticals' underperformance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

XLV : 153.01 (+0.61%)
VRTX : 446.83 (+1.15%)
REGN : 635.45 (+1.07%)
AMGN : 349.58 (+1.15%)
2 Unpopular Stocks That Should Get More Attention and 1 We Question

2 Unpopular Stocks That Should Get More Attention and 1 We Question

RBCAA : 84.50 (+0.38%)
BTSG : 57.40 (unch)
AMGN : 349.58 (+1.15%)
How Is Pfizer's Stock Performance Compared to Other Healthcare Stocks?

Due to Pfizer’s underperformance relative to its peers over the past year, Wall Street analysts remain cautious about the stock’s prospects

XLV : 153.01 (+0.61%)
AMGN : 349.58 (+1.15%)
PFE : 26.04 (+1.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 363.67
2nd Resistance Point 360.09
1st Resistance Point 354.83
Last Price 349.58
1st Support Level 345.99
2nd Support Level 342.41
3rd Support Level 337.15

See More

52-Week High 391.29
Last Price 349.58
Fibonacci 61.8% 344.13
Fibonacci 50% 329.56
Fibonacci 38.2% 314.99
52-Week Low 267.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.